Authors: Wolpin BM, Rubinson DA, Wang X, Chan JA, Cleary JM, Enzinger PC et al. PMID: 24821822 PMCID: PMC4041680 DOI: 10.1634/theoncologist.2014-0086 Abstract Background: Autophagy is a catabolic pathway that permits cells to recycle intracellular macromolecules, and its inhibition reduces pancreatic cancer growth in model systems. We evaluated hydoxychloroquine (HCQ), an inhibitor of autophagy, in patients [...]

Authors: Ruiz-Irastorza G, Khamashta MA PMID: 18413405 DOI: 10.1177/0961203307086643 Abstract No abstract available Keywords: Hydroxychloroquine, lupus Source: https://journals.sagepub.com/doi/pdf/10.1177/0961203307086643 Archive: https://archive.is/caIhQ

What does it cost to do the right thing in healthcare? A former hospital CEO, a board-certified pathologist, and an ICU physician share what they've learned.

Dr. Joseph Varon tells Full Measure why he launched the Journal of Independent Medicine to counter Big Pharma's grip on medical publishing.

Wednesday night is normally webinar night for us at IMA, but this week our team is taking a much-deserved break for the holidays. Catch up with some of the best webinars of the year!

You’ve got to hand it to the government. For a system that’s historically been about as nurturing as a cactus in a snowstorm, it’s somehow managed to develop a tender, almost maternal instinct to try to save us from ourselves. (*But only sometimes.)

In this week's IMA Webinar, our experts discuss the relatively new concept of "Spike Protein Susceptibility." Join the study authors as they break down their vital research, revealing why COVID vaccine reactions can differ so dramatically.

Dr. Chris Martenson is joined by former Deputy Assistant Secretary of HHS David Mansdoerfer and special guests—Sen. Ron Johnson, and IMA Senior Fellow Dr. Jordan Vaughn—for a timely breakdown of the May 21, 2025, U.S. Senate hearing on COVID-19 vaccine development and safety.

A newly published review in the Journal of Independent Medicine presents compelling data from a southern California clinic that treated thousands of COVID-19 patients during the height of the pandemic—with outcomes that significantly outperformed regional and national trends.

From Nobel Prize-winner to 'horse paste' and back again. in this month's Here's A Thought... Jenna McCarthy looks at the round-trip of the miracle drug that could (and does!)